1. Home/
  2. Compounds/
  3. doxorubicin:navitoclax (2:1 mol/mol)

doxorubicin:navitoclax (2:1 mol/mol)

Synonyms

SourcesNames Used
CTRPv2doxorubicin:navitoclax (2:1 mol/mol)
PharmacoGx doxorubicin:navitoclax (2:1 mol/mol)

FDA Approval Status

Not Approved
Dataset Select
Download Data as CSV

Top molecular features associated with response to doxorubicin:navitoclax (2:1 mol/mol)


Feature TypeStandardized
Nominal ANOVA
mRNA AC006486.9 CTRPv2 pan-cancer AAC 0.15 6e-06
mRNA DDX25 CTRPv2 pan-cancer AAC 0.15 6e-06
mRNA SREBF2 CTRPv2 pan-cancer AAC 0.16 6e-06
mRNA ZBTB12 CTRPv2 pan-cancer AAC 0.16 6e-06
mRNA CNPY1 CTRPv2 pan-cancer AAC 0.14 6e-06
mRNA MCM9 CTRPv2 pan-cancer AAC 0.15 6e-06
mRNA FTH1 CTRPv2 pan-cancer AAC -0.15 6e-06
mRNA HECA CTRPv2 pan-cancer AAC 0.16 6e-06
mRNA PUM1 CTRPv2 pan-cancer AAC 0.15 6e-06
mRNA LRRC37A CTRPv2 pan-cancer AAC 0.16 6e-06
Download CSV